This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

Performance Under Pressure

Product safety and drug development


When golf champions win, it's often in the spotlight, watched carefully by competitors, fans and television audiences potentially totaling millions of people. The stress is extraordinary. Likewise, pharmaceutical, biotech and medical device companies are closely scrutinized by regulators, investors, the medical community, patients and the public. These businesses have the potential to change lives, but do so under extraordinary pressure.

Deloitte works with life sciences companies to develop practical, executable strategies for addressing critical issues such as pharmacovigilance (PV) execution and drug safety compliance, document management, adverse events processing and product safety monitoring. Our practitioners have significant experience across a broad cross-section of life sciences organizations addressing PV. Deloitte is recognized as world class and a thought leader in the life sciences industry.

As used in this document, “Deloitte” means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.

Related links

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options

Stay connected